TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG

Welcome to the Brand page for “TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG”, which is offered here for The mark consists of the word tecentriq with atezolizumab injection for intravenous use 1200 mg under it. the first t in tecentriq has three arrows pointing inwards in a circle above it in the upper left hand corner.;pharmaceutical oncology preparations;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG” is believed to be currently owned by “GENENTECH, INC.”